| | Other Issues: previous | next | latest | archiveReviews Update on the use of trandolapril in the management of cardiovascular disorders Ariel Diaz and Anique Ducharme Vasc Health Risk Manag. 2008 December; 4(6): 1147–1158. PMCID: PMC2663436 Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine Menno T Pruijm, Marc P Maillard, and Michel Burnier Vasc Health Risk Manag. 2008 December; 4(6): 1159–1166. PMCID: PMC2663443 Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes Marc K Israel, Eva Istvan, and Michelle A Baron Vasc Health Risk Manag. 2008 December; 4(6): 1167–1178. PMCID: PMC2663444 Peripheral artery disease: potential role of ACE-inhibitor therapy Giuseppe Coppola, Giuseppe Romano, Egle Corrado, Rosa Maria Grisanti, and Salvatore Novo Vasc Health Risk Manag. 2008 December; 4(6): 1179–1187. PMCID: PMC2663435 Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes Floris Alexander van de Laar Vasc Health Risk Manag. 2008 December; 4(6): 1189–1195. PMCID: PMC2663450 Safety and efficacy of cilostazol in the management of intermittent claudication Yung-Wei Chi, Carl J Lavie, Richard V Milani, and Christopher J White Vasc Health Risk Manag. 2008 December; 4(6): 1197–1203. PMCID: PMC2663440 Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy Kalathil K Sureshkumar Vasc Health Risk Manag. 2008 December; 4(6): 1205–1220. PMCID: PMC2663460 Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potential Nasser Mikhail Vasc Health Risk Manag. 2008 December; 4(6): 1221–1227. PMCID: PMC2663457 Cardiometabolic risk in psoriasis: differential effects of biologic agents Mariana J Kaplan Vasc Health Risk Manag. 2008 December; 4(6): 1229–1235. PMCID: PMC2663453 Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension Luis M Ruilope Vasc Health Risk Manag. 2008 December; 4(6): 1237–1248. PMCID: PMC2663442 Long-acting nifedipine in the management of the hypertensive patient Morgan E Snider, Donald S Nuzum, and Angie Veverka Vasc Health Risk Manag. 2008 December; 4(6): 1249–1257. PMCID: PMC2663456 Managing hypercholesterolemia and its correlation with carotid plaque morphology in patients undergoing carotid endarterectomy Kittipan Rerkasem, Patrick J Gallagher, Robert F Grimble, Philip C Calder, and Clifford P Shearman Vasc Health Risk Manag. 2008 December; 4(6): 1259–1264. PMCID: PMC2663431 Beta-glucans in the treatment of diabetes and associated cardiovascular risks Jiezhong Chen and Kenneth Raymond Vasc Health Risk Manag. 2008 December; 4(6): 1265–1272. PMCID: PMC2663451 Role of stress fibers and focal adhesions as a mediator for mechano-signal transduction in endothelial cells in situ Kazuo Katoh, Yumiko Kano, and Shigeo Ookawara Vasc Health Risk Manag. 2008 December; 4(6): 1273–1282. PMCID: PMC2663434 Proinsulin C-peptide: Friend or foe in the development of diabetes-associated complications? Lina Nordquist and M Johansson Vasc Health Risk Manag. 2008 December; 4(6): 1283–1288. PMCID: PMC2663462 Role of TGF-β on cardiac structural and electrical remodeling Roberto Ramos-Mondragón, Carlos A Galindo, and Guillermo Avila Vasc Health Risk Manag. 2008 December; 4(6): 1289–1300. PMCID: PMC2663446 Pathophysiology of placentation abnormalities in pregnancy-induced hypertension Mitsuko Furuya, Junji Ishida, Ichiro Aoki, and Akiyoshi Fukamizu Vasc Health Risk Manag. 2008 December; 4(6): 1301–1313. PMCID: PMC2663465 The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of this preferential target Jean-Jacques Mourad Vasc Health Risk Manag. 2008 December; 4(6): 1315–1325. PMCID: PMC2663439 Mechanisms of endothelial dysfunction in obstructive sleep apnea Amy Atkeson and Sanja Jelic Vasc Health Risk Manag. 2008 December; 4(6): 1327–1335. PMCID: PMC2663447 Thrombosis in the critically ill neonate: incidence, diagnosis, and management Alex Veldman, Marcel F Nold, and Ina Michel-Behnke Vasc Health Risk Manag. 2008 December; 4(6): 1337–1348. PMCID: PMC2663458 Vildagliptin: a new oral treatment for type 2 diabetes mellitus Chantal Mathieu and Evy Degrande Vasc Health Risk Manag. 2008 December; 4(6): 1349–1360. PMCID: PMC2663430 Arterial pulse wave velocity, inflammatory markers, pathological GH and IGF states, cardiovascular and cerebrovascular disease Michael R Graham, Peter Evans, Bruce Davies, and Julien S Baker Vasc Health Risk Manag. 2008 December; 4(6): 1361–1371. PMCID: PMC2663454 Emergence of new oral antithrombotics: a critical appraisal of their clinical potential Michael Rud Lassen and Volker Laux Vasc Health Risk Manag. 2008 December; 4(6): 1373–1386. PMCID: PMC2663445 Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction William H Frishman, Linda S Henderson, and Mary Ann Lukas Vasc Health Risk Manag. 2008 December; 4(6): 1387–1400. PMCID: PMC2663448 Rapid Communication Dual factor pulse pressure: body mass index and outcome in type 2 diabetic subjects on maintenance hemodialysis. A longitudinal study 2003–2006 Lydia Foucan, Kheira Hue, Jocelyn Inamo, Jacqueline Deloumeaux, Anne Blanchet-Deverly, Henry Merault, and Jean-Marc Gabriel Vasc Health Risk Manag. 2008 December; 4(6): 1401–1406. PMCID: PMC2663455 Original Research Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice: a randomized, open-label, parallel-group, multi-center study: the DISCOVERY-Beta study Toivo Laks, Ester Keba, Mariann Leiner, Eero Merilind, Mall Petersen, Sirje Reinmets, Sille Väli, Terje Sööt, and Karin Otter Vasc Health Risk Manag. 2008 December; 4(6): 1407–1416. PMCID: PMC2663459 The effects of prior calcium channel blocker therapy on creatine kinase-MB levels after percutaneous coronary interventions Oyku Gulmez, Ilyas Atar, Bülent Ozin, Mehmet Emin Korkmaz, Asli Atar, Alp Aydinalp, Aylin Yildirir, and Haldun Muderrisoglu Vasc Health Risk Manag. 2008 December; 4(6): 1417–1422. PMCID: PMC2663464 Effect of conjugated linoleic acid, vitamin E and their combination on lipid profiles and blood pressure of Iranian adults with active rheumatoid arthritis Naheed Aryaeian, Farhad Shahram, Mahmoud Djalali, Mohammad R Eshragian, Abolghasem Djazayeri, Abdolfatah Sarrafnejad, Nasim Naderi, Maryam Chamari, Fariha Fatehi, and Mahnaz Zarei Vasc Health Risk Manag. 2008 December; 4(6): 1423–1432. PMCID: PMC2663461 Effect of statin therapy on serum activity of proteinases and cytokines in patients with abdominal aortic aneurysm Bernd Muehling, Alexander Oberhuber, Hubert Schelzig, Gisela Bischoff, Nikolaus Marx, Ludger Sunder-Plassmann, and Karl H Orend Vasc Health Risk Manag. 2008 December; 4(6): 1433–1437. PMCID: PMC2663432 Omega-3 fatty acids plus rosuvastatin improves endothelial function in South Asians with dyslipidemia Catalin Mindrescu, Rakesh P Gupta, Eileen V Hermance, Mary C DeVoe, Vikas R Soma, John T Coppola, and Cezar S Staniloae Vasc Health Risk Manag. 2008 December; 4(6): 1439–1447. PMCID: PMC2663433 Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes Sandra Beer, François Feihl, Juan Ruiz, Irène Juhan-Vague, Marie-Françoise Aillaud, Sandrine Golay Wetzel, Lucas Liaudet, Rolf C Gaillard, and Bernard Waeber Vasc Health Risk Manag. 2008 December; 4(6): 1449–1458. PMCID: PMC2663449 Characterization of the vasodilatory action of testosterone in the human pulmonary circulation Alyson M Smith, Robert T Bennett, T Hugh Jones, Mike E Cowen, Kevin S Channer, and Richard D Jones Vasc Health Risk Manag. 2008 December; 4(6): 1459–1466. PMCID: PMC2663441 Sleep restriction increases white blood cells, mainly neutrophil count, in young healthy men: A pilot study Karim Zouaoui Boudjeltia, Brice Faraut, Patricia Stenuit, Maria José Esposito, Michal Dyzma, Dany Brohée, Jean Ducobu, Michel Vanhaeverbeek, and Myriam Kerkhofs Vasc Health Risk Manag. 2008 December; 4(6): 1467–1470. PMCID: PMC2663438 Case Reports Association of angiitis of central nervous system, cerebral amyloid angiopathy, and Alzheimer’s disease: Report of an autopsy case Cédric Annweiler, Marc Paccalin, Gilles Berrut, Caroline Hommet, Christian Lavigne, Jean-Paul Saint-André, and Olivier Beauchet Vasc Health Risk Manag. 2008 December; 4(6): 1471–1474. PMCID: PMC2663463 Anabolic steroids, acute myocardial infarction and polycythemia: A case report and review of the literature Kathleen Stergiopoulos, Joseph J Brennan, Robin Mathews, John F Setaro, and Smadar Kort Vasc Health Risk Manag. 2008 December; 4(6): 1475–1480. PMCID: PMC2663437 Corrigendum Vasc Health Risk Manag. 2008 December; 4(6): 1481. PMCID: PMC2663452 Corrects: Corrigendum. Vasc Health Risk Manag. 2008 December; 4(6): 1481. |